CF PHARMTECH, INC. - H SHARES
(HKEX: 2652)
CF PharmTech, Inc engages in the research, development, production and sale of respiratory diseases pharmaceutical products. The company focuses on complex products and platforms, innovative medicines, and medical devices. It also offers inhalers, asthma treatment products including Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. The company was founded by Liang Wenqing and Li Li in 2007 and is headquartered in Suzhou, China.
36.140 -
+0.640
(+1.80%)
Range
35.200 - 37.200
(5.68%)
Open
36.000
Previous Close
35.500
Bid Price
36.140
Bid Volume
('000)
0.5
Ask Price
36.640
Ask Volume
('000)
1
Volume
('000)
358.4
Value
12,980,263
Remark
-
Delayed prices. Updated at 29 Jan 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
